Kewaunee Scientific (US:KEQU)2019-12-16 20:45Sales Performance - Sales for the quarter were $39,722,000, a 6.6% increase from $37,278,000 in the comparable period of the prior year[62] - Domestic sales for the quarter were $31,584,000, up 3.1% from $30,622,000 in the comparable period of the prior year[62] - International sales for the quarter were $8,138,000, up 22.3% from $6,656,000 in the comparable period of the prior year[62] Profitability - The gross profit margin for the three months ended October 31, 2019 was 15.9%, down from 20.6% in the comparable quarter of the prior year[65] - Net loss was $2,178,000, or $0.79 per diluted share, for the three months ended October 31, 2019, compared to net earnings of $1,332,000, or $0.48 per diluted share, in the prior year[72] Operating Expenses - Operating expenses for the three months ended October 31, 2019 were $6,355,000, or 16.0% of sales, unchanged from the prior year[66] Taxation - The effective tax rate for the three months ended October 31, 2019 was 1,267.7%, compared to 22.0% for the same period in the prior year[68] Order Backlog - The Company's order backlog was $92 million at October 31, 2019, down from $101 million at October 31, 2018[64] Working Capital - The Company had working capital of $30,841,000 at October 31, 2019, compared to $32,624,000 at April 30, 2019[74] Cash Flow - The Company provided cash of $4,496,000 during the six months ended October 31, 2019, primarily from operations[76]